Re: Farmas USA
NVAX
Stanley, hoy en el programa de Cramer.
Stanley C. Erck, President and Chief Executive Officer, will appear on CNBC's Mad Money with Jim Cramer today, January 12 at 6:00 p.m. ET to discuss Novavax' pivotal Phase 3 clinical trial, known as Resolve™, of the RSV F Vaccine in older adults. Novavax recently announced complete enrollment of this 11,850 participant trial in only five weeks and ahead of the RSV season. Mr. Erck will also discuss Novavax' global pivotal Phase 3 clinical trial, known as Prepare™, of the RSV F Vaccine in healthy pregnant women. This trial is supported by a grant of up to $89 million from the Bill & Melinda Gates Foundation.
PS: yo haría esa entrada ahora si tuviera pasta.
«Después de nada, o después de todo/ supe que todo no era más que nada.»